Clinical studies on administration of taurolin in severe sepsis: a preliminary study.
McCartney
A C
AC
University Department of Bacteriology, Royal Infirmary, Glasgow, Scotland.
Browne
M K
MK
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004731:Endotoxins / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012772:Shock, Septic / Q000097:blood / Q000188:drug therapy; D013530:Surgical Wound Infection / Q000097:blood / Q000188:drug therapy; D013654:Taurine / Q000031:analogs & derivatives*; D013829:Thiadiazines / Q000627:therapeutic use*; D013843:Thiazines / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D004731:Endotoxins; D013829:Thiadiazines; D013843:Thiazines; D013654:Taurine; C012566:taurolidine